Parexel (PRXL) Tops Q1 EPS by 6c

Parexel (NASDAQ: PRXL) reported Q1 EPS of $0.70, $0.06 better than the analyst estimate of $0.64. Revenue for the quarter came in at $585.2 million versus the consensus estimate of $511.77 million.

Parexel sees Q2 2016 EPS of $0.66-$0.74, versus the consensus of $0.75. Parexel sees Q2 2016 revenue of $518-528 million, versus the consensus of $534.4 million.

Parexel sees FY2015 EPS of $3.19-$3.39, versus prior guidance of $3.02-$3.38 and the consensus of $3.23. Parexel sees FY2015 revenue of $2.12-2.16 billion, versus prior guidance of $2.16-2.21 billion and the consensus of $2.18 billion.

For earnings history and earnings-related data on Parexel (PRXL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c